Crinetics Pharmaceuticals, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers the Annual Meeting of Stockholders held on June 18, 2026. The meeting was conducted via live audio webcast. Approximately 97% of eligible outstanding shares (102,030,415 shares) were present virtually or by proxy.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting results.
Material Changes and Voting Results
Three proposals were presented and voted upon at the Annual Meeting:
- Proposal One (Election of Directors): Stockholders approved the election of three Class II directors for three-year terms expiring in 2029.
- Caren Deardorf: 73,454,076 votes For; 23,532,328 votes Withheld.
- Weston Nichols, Ph.D.: 90,208,564 votes For; 6,777,840 votes Withheld.
- Stephanie S. Okey, M.S.: 72,225,313 votes For; 24,761,091 votes Withheld.
- Proposal Two (Ratification of Auditors): Stockholders ratified the selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
- 101,675,974 votes For; 341,727 votes Against; 12,714 Abstentions.
- Proposal Three (Executive Compensation): Stockholders approved, on an advisory basis, the compensation of the named executive officers.
- 91,657,992 votes For; 2,698,538 votes Against; 2,629,874 Abstentions.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Verify the specific terms and compensation packages for the newly elected directors (Caren Deardorf, Weston Nichols, and Stephanie S. Okey).
- Confirm the engagement letter details with PricewaterhouseCoopers LLP for the 2026 fiscal year.
- Review the definitive proxy statement for the full breakdown of executive compensation approved in Proposal Three.
- Note the high abstention rate (approx. 2.6 million votes) on the executive compensation proposal.